Roger has extensive experience in intellectual property infringement litigation, licensing, strategy planning, and antitrust and competition regulation advice. Roger is active in trademark, copyright, and patent litigation for various industries. In 2019, represented by Roger, AVIS was awarded 3 million USD by the Intellectual Property Court in a trademark infringement case. In 2019, Entegris was awarded 32 million USD in a patent infringement case. In 2017, Philips was awarded 35 million USD in a patent infringement suit. In 2013, Philips was awarded 10 million USD in a patent case. In 2011, ESI, a NASDAQ-listed company based in Oregon, was awarded 24 million USD in a patent infringement suit. In 2010, another case represented by Roger, Philips was awarded 68 million USD for patent infringement damages. In 2009, the Intellectual Property Court awarded Philips 75 million USD as royalty of patent licensing. In 2007, in a landmark case that he participated in, the Taipei District Court awarded Celanese 68 million USD as damages for patent infringement. Known for his in-depth understanding of complex matters involving intellectual property and ability to provide innovative and constructive solutions, Roger is regularly invited to speak at seminars and workshops and publish articles on intellectual property and antitrust laws. Roger has also assisted Taiwanese government agencies in amendments to intellectual property and competition-related laws and regulations
Intellectual Property Litigation and Licensing; Antitrust and Competition
Secretary General to the Taiwan Patent Attorneys Association
Adjunct assistant professor in Intellectual Property, National Taipei University Law School
Arbitrator, the Arbitration Association of Republic of China
admitted 1997, Attorney; 1997, Patent Agent; 2009, Patent Attorney, R.O.C. (Taiwan)
Taipei Bar Association
Taoyuan Bar Association.
Hsinchu Bar Association
2023 |
法律解釋方法初探──兼論形式法學派與現實法學派之百年論爭 月旦律評19期 |
2023 |
藥品專利權期間延長之立法目的及其落實─從新近實務爭議談起 月旦法學339期 |
2023 |
Court rules in favour of pharmaceutical companies that market category two new drugs
ILO IP Newsletter (20230424) |
2023 |
Taipei High Administrative Court's Latest Ruling: Patent Information of "Category II New Drugs" Allowed to be Submitted in Patent Linkage Registration System
LEXOLOGY |
2023 |
2022年最高法院及最高行政法院關鍵專利判決 月旦律評12期 |
2023 |
Taipei High Administrative Court's Latest Ruling: Patent Information of "Category II New Drugs" Allowed to be Submitted in Patent Linkage Registration System
LEE & LI Bulletin - January 2023 |
2022 |
Taipei High Administrative Court's Latest Ruling: Patent Information of "Category II New Drugs" Allowed to be Submitted in Patent Linkage Registration System
LEXOLOGY |
2018 |
Important aspects of forthcoming patent linkage system regulations ILO IP Newsletter |
2018 |
法庭之友意見,105年度行專更(一)字第4號發明專利舉發事件有關通常知識者界定所涉爭議 參見智慧財產法院官網 |
2018 |
Taiwan rolls out US-like patent linkage regime iam March |
2014 |
Significant Changes Proposed To Mergers and Acquisitions Act WORLD SECURITIES LAW REPORT VOL. 20 NO.2 |
2013 |
Taiwan Fair Trade Commission's Changing Stance Towards Patent Pools World Intellectual Property Report, Vol.27, No.8, |
More |
2023 | 2023 TIPA International Symposium on Trademark Protection and Litigation | Discussant Intellectual Property and Commercial Court & Intellectual Property Office, Ministry of Economic Affairs |
2023 | Latest development of the patent term extension—court case law and TIPO's practice | Speaker International Research-Based Pharmaceutical Manufacturers Association(IRPMA), Lee and Li, Attorneys-at-Law, Lee and Li Foundation |
2023 | Key Patent Court Cases in 2022 in Taiwan | Speaker Lee and Li, Attorneys-at-Law |
2023 | Introduction to the Unitary Patent System (UPS) –Strategy for Prosecution and Litigation | Moderator Lee and Li, Attorneys-at-Law |
2022 | 2022 TIPA IP Symposium: Trial Model of Patent Litigation | Discussant Intellectual Property and Commercial Court & Intellectual Property Office, Ministry of Economic Affairs |